化膿性汗腺炎治療の世界市場（～2026年）

• 英文タイトル：Global Hidradenitis Suppurativa Treatment Market Size, Status and Forecast 2020-2026

• レポートコード：MRC2-11QY12181
• 出版社/出版日：QYResearch / 2020年11月25日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、91ページ
• 納品方法：Eメール（納期：2~3日）
• 産業分類：ヘルスケア

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,170,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

当調査資料は化膿性汗腺炎治療のグローバル市場について調査・分析したレポートです。種類別（医薬品、手術、その他）市場規模、用途別（病院、クリニック、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別化膿性汗腺炎治療の競争状況、市場シェア
・世界の化膿性汗腺炎治療市場：種類別市場規模 2015年-2020年（医薬品、手術、その他）
・世界の化膿性汗腺炎治療市場：種類別市場規模予測 2021年-2026年（医薬品、手術、その他）
・世界の化膿性汗腺炎治療市場：用途別市場規模 2015年-2020年（病院、クリニック、その他）
・世界の化膿性汗腺炎治療市場：用途別市場規模予測 2021年-2026年（病院、クリニック、その他）
・北米の化膿性汗腺炎治療市場分析：米国、カナダ
・ヨーロッパの化膿性汗腺炎治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの化膿性汗腺炎治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の化膿性汗腺炎治療市場分析：メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの化膿性汗腺炎治療市場分析：トルコ、サウジアラビア、UAE等
・企業情報（企業概要、製品概要、販売量、企業動向）
- 掲載企業（変更可能性あり）：GlaxoSmithKline、Johnson & Johnson、Merck、Pfizer、AbbVie、Allergan、AstraZeneca
・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

Hidradenitis suppurativa is a rare, inflammatory skin condition that begins as small and painful pimples on the skin. This medical condition is most common between the ages of 20-40 years. Prevalence of hidradenitis suppurativa is three times more common in females than in males.
Considering the global scenario of the market, North America holds the largest market share due to various factors such as increasing cases of skin diseases and related medical complications.

Market Analysis and Insights: Global Hidradenitis Suppurativa Treatment Market
The global Hidradenitis Suppurativa Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Hidradenitis Suppurativa Treatment Scope and Market Size
Hidradenitis Suppurativa Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Hidradenitis Suppurativa Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
GlaxoSmithKline
Johnson & Johnson
Merck
Pfizer
AbbVie
Allergan
AstraZeneca
…

Market segment by Type, the product can be split into
Medications
Surgery
Others
Market segment by Application, split into
Hospitals
Clinics
Others

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Hidradenitis Suppurativa Treatment Revenue
1.4 Market by Type
1.4.1 Global Hidradenitis Suppurativa Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Medications
1.4.3 Surgery
1.4.4 Others
1.5 Market by Application
1.5.1 Global Hidradenitis Suppurativa Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Hidradenitis Suppurativa Treatment Market Perspective (2015-2026)
2.2 Global Hidradenitis Suppurativa Treatment Growth Trends by Regions
2.2.1 Hidradenitis Suppurativa Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Hidradenitis Suppurativa Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Hidradenitis Suppurativa Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Hidradenitis Suppurativa Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Hidradenitis Suppurativa Treatment Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Hidradenitis Suppurativa Treatment Players by Market Size
3.1.1 Global Top Hidradenitis Suppurativa Treatment Players by Revenue (2015-2020)
3.1.2 Global Hidradenitis Suppurativa Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Hidradenitis Suppurativa Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Hidradenitis Suppurativa Treatment Market Concentration Ratio
3.2.1 Global Hidradenitis Suppurativa Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Hidradenitis Suppurativa Treatment Revenue in 2019
3.3 Hidradenitis Suppurativa Treatment Key Players Head office and Area Served
3.4 Key Players Hidradenitis Suppurativa Treatment Product Solution and Service
3.5 Date of Enter into Hidradenitis Suppurativa Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Hidradenitis Suppurativa Treatment Historic Market Size by Type (2015-2020)
4.2 Global Hidradenitis Suppurativa Treatment Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Hidradenitis Suppurativa Treatment Market Size by Application (2015-2020)
5.2 Global Hidradenitis Suppurativa Treatment Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Hidradenitis Suppurativa Treatment Market Size (2015-2020)
6.2 Hidradenitis Suppurativa Treatment Key Players in North America (2019-2020)
6.3 North America Hidradenitis Suppurativa Treatment Market Size by Type (2015-2020)
6.4 North America Hidradenitis Suppurativa Treatment Market Size by Application (2015-2020)

7 Europe
7.1 Europe Hidradenitis Suppurativa Treatment Market Size (2015-2020)
7.2 Hidradenitis Suppurativa Treatment Key Players in Europe (2019-2020)
7.3 Europe Hidradenitis Suppurativa Treatment Market Size by Type (2015-2020)
7.4 Europe Hidradenitis Suppurativa Treatment Market Size by Application (2015-2020)

8 China
8.1 China Hidradenitis Suppurativa Treatment Market Size (2015-2020)
8.2 Hidradenitis Suppurativa Treatment Key Players in China (2019-2020)
8.3 China Hidradenitis Suppurativa Treatment Market Size by Type (2015-2020)
8.4 China Hidradenitis Suppurativa Treatment Market Size by Application (2015-2020)

9 Japan
9.1 Japan Hidradenitis Suppurativa Treatment Market Size (2015-2020)
9.2 Hidradenitis Suppurativa Treatment Key Players in Japan (2019-2020)
9.3 Japan Hidradenitis Suppurativa Treatment Market Size by Type (2015-2020)
9.4 Japan Hidradenitis Suppurativa Treatment Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Hidradenitis Suppurativa Treatment Market Size (2015-2020)
10.2 Hidradenitis Suppurativa Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Hidradenitis Suppurativa Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Hidradenitis Suppurativa Treatment Market Size by Application (2015-2020)

11 India
11.1 India Hidradenitis Suppurativa Treatment Market Size (2015-2020)
11.2 Hidradenitis Suppurativa Treatment Key Players in India (2019-2020)
11.3 India Hidradenitis Suppurativa Treatment Market Size by Type (2015-2020)
11.4 India Hidradenitis Suppurativa Treatment Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Hidradenitis Suppurativa Treatment Market Size (2015-2020)
12.2 Hidradenitis Suppurativa Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Hidradenitis Suppurativa Treatment Market Size by Type (2015-2020)
12.4 Central & South America Hidradenitis Suppurativa Treatment Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 GlaxoSmithKline
13.1.1 GlaxoSmithKline Company Details
13.1.2 GlaxoSmithKline Business Overview
13.1.3 GlaxoSmithKline Hidradenitis Suppurativa Treatment Introduction
13.1.4 GlaxoSmithKline Revenue in Hidradenitis Suppurativa Treatment Business (2015-2020))
13.1.5 GlaxoSmithKline Recent Development
13.2 Johnson & Johnson
13.2.1 Johnson & Johnson Company Details
13.2.2 Johnson & Johnson Business Overview
13.2.3 Johnson & Johnson Hidradenitis Suppurativa Treatment Introduction
13.2.4 Johnson & Johnson Revenue in Hidradenitis Suppurativa Treatment Business (2015-2020)
13.2.5 Johnson & Johnson Recent Development
13.3 Merck
13.3.1 Merck Company Details
13.3.2 Merck Business Overview
13.3.3 Merck Hidradenitis Suppurativa Treatment Introduction
13.3.4 Merck Revenue in Hidradenitis Suppurativa Treatment Business (2015-2020)
13.3.5 Merck Recent Development
13.4 Pfizer
13.4.1 Pfizer Company Details
13.4.2 Pfizer Business Overview
13.4.3 Pfizer Hidradenitis Suppurativa Treatment Introduction
13.4.4 Pfizer Revenue in Hidradenitis Suppurativa Treatment Business (2015-2020)
13.4.5 Pfizer Recent Development
13.5 AbbVie
13.5.1 AbbVie Company Details
13.5.2 AbbVie Business Overview
13.5.3 AbbVie Hidradenitis Suppurativa Treatment Introduction
13.5.4 AbbVie Revenue in Hidradenitis Suppurativa Treatment Business (2015-2020)
13.5.5 AbbVie Recent Development
13.6 Allergan
13.6.1 Allergan Company Details
13.6.2 Allergan Business Overview
13.6.3 Allergan Hidradenitis Suppurativa Treatment Introduction
13.6.4 Allergan Revenue in Hidradenitis Suppurativa Treatment Business (2015-2020)
13.6.5 Allergan Recent Development
13.7 AstraZeneca
13.7.1 AstraZeneca Company Details
13.7.2 AstraZeneca Business Overview
13.7.3 AstraZeneca Hidradenitis Suppurativa Treatment Introduction
13.7.4 AstraZeneca Revenue in Hidradenitis Suppurativa Treatment Business (2015-2020)
13.7.5 AstraZeneca Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Hidradenitis Suppurativa Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Hidradenitis Suppurativa Treatment Revenue
Table 3. Ranking of Global Top Hidradenitis Suppurativa Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Hidradenitis Suppurativa Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Medications
Table 6. Key Players of Surgery
Table 7. Key Players of Others
Table 8. Global Hidradenitis Suppurativa Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Hidradenitis Suppurativa Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Hidradenitis Suppurativa Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Hidradenitis Suppurativa Treatment Market Share by Regions (2015-2020)
Table 12. Global Hidradenitis Suppurativa Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Hidradenitis Suppurativa Treatment Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Hidradenitis Suppurativa Treatment Market Growth Strategy
Table 18. Main Points Interviewed from Key Hidradenitis Suppurativa Treatment Players
Table 19. Global Hidradenitis Suppurativa Treatment Revenue by Players (2015-2020) (Million US$)
Table 20. Global Hidradenitis Suppurativa Treatment Market Share by Players (2015-2020)
Table 21. Global Top Hidradenitis Suppurativa Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hidradenitis Suppurativa Treatment as of 2019)
Table 22. Global Hidradenitis Suppurativa Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Hidradenitis Suppurativa Treatment Product Solution and Service
Table 25. Date of Enter into Hidradenitis Suppurativa Treatment Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Hidradenitis Suppurativa Treatment Market Size by Type (2015-2020) (Million US$)
Table 28. Global Hidradenitis Suppurativa Treatment Market Size Share by Type (2015-2020)
Table 29. Global Hidradenitis Suppurativa Treatment Revenue Market Share by Type (2021-2026)
Table 30. Global Hidradenitis Suppurativa Treatment Market Size Share by Application (2015-2020)
Table 31. Global Hidradenitis Suppurativa Treatment Market Size by Application (2015-2020) (Million US$)
Table 32. Global Hidradenitis Suppurativa Treatment Market Size Share by Application (2021-2026)
Table 33. North America Key Players Hidradenitis Suppurativa Treatment Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Hidradenitis Suppurativa Treatment Market Share (2019-2020)
Table 35. North America Hidradenitis Suppurativa Treatment Market Size by Type (2015-2020) (Million US$)
Table 36. North America Hidradenitis Suppurativa Treatment Market Share by Type (2015-2020)
Table 37. North America Hidradenitis Suppurativa Treatment Market Size by Application (2015-2020) (Million US$)
Table 38. North America Hidradenitis Suppurativa Treatment Market Share by Application (2015-2020)
Table 39. Europe Key Players Hidradenitis Suppurativa Treatment Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Hidradenitis Suppurativa Treatment Market Share (2019-2020)
Table 41. Europe Hidradenitis Suppurativa Treatment Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Hidradenitis Suppurativa Treatment Market Share by Type (2015-2020)
Table 43. Europe Hidradenitis Suppurativa Treatment Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Hidradenitis Suppurativa Treatment Market Share by Application (2015-2020)
Table 45. China Key Players Hidradenitis Suppurativa Treatment Revenue (2019-2020) (Million US$)
Table 46. China Key Players Hidradenitis Suppurativa Treatment Market Share (2019-2020)
Table 47. China Hidradenitis Suppurativa Treatment Market Size by Type (2015-2020) (Million US$)
Table 48. China Hidradenitis Suppurativa Treatment Market Share by Type (2015-2020)
Table 49. China Hidradenitis Suppurativa Treatment Market Size by Application (2015-2020) (Million US$)
Table 50. China Hidradenitis Suppurativa Treatment Market Share by Application (2015-2020)
Table 51. Japan Key Players Hidradenitis Suppurativa Treatment Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Hidradenitis Suppurativa Treatment Market Share (2019-2020)
Table 53. Japan Hidradenitis Suppurativa Treatment Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Hidradenitis Suppurativa Treatment Market Share by Type (2015-2020)
Table 55. Japan Hidradenitis Suppurativa Treatment Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Hidradenitis Suppurativa Treatment Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Hidradenitis Suppurativa Treatment Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Hidradenitis Suppurativa Treatment Market Share (2019-2020)
Table 59. Southeast Asia Hidradenitis Suppurativa Treatment Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Hidradenitis Suppurativa Treatment Market Share by Type (2015-2020)
Table 61. Southeast Asia Hidradenitis Suppurativa Treatment Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Hidradenitis Suppurativa Treatment Market Share by Application (2015-2020)
Table 63. India Key Players Hidradenitis Suppurativa Treatment Revenue (2019-2020) (Million US$)
Table 64. India Key Players Hidradenitis Suppurativa Treatment Market Share (2019-2020)
Table 65. India Hidradenitis Suppurativa Treatment Market Size by Type (2015-2020) (Million US$)
Table 66. India Hidradenitis Suppurativa Treatment Market Share by Type (2015-2020)
Table 67. India Hidradenitis Suppurativa Treatment Market Size by Application (2015-2020) (Million US$)
Table 68. India Hidradenitis Suppurativa Treatment Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Hidradenitis Suppurativa Treatment Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Hidradenitis Suppurativa Treatment Market Share (2019-2020)
Table 71. Central & South America Hidradenitis Suppurativa Treatment Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Hidradenitis Suppurativa Treatment Market Share by Type (2015-2020)
Table 73. Central & South America Hidradenitis Suppurativa Treatment Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Hidradenitis Suppurativa Treatment Market Share by Application (2015-2020)
Table 75. GlaxoSmithKline Company Details
Table 76. GlaxoSmithKline Business Overview
Table 77. GlaxoSmithKline Product
Table 78. GlaxoSmithKline Revenue in Hidradenitis Suppurativa Treatment Business (2015-2020) (Million US$)
Table 79. GlaxoSmithKline Recent Development
Table 80. Johnson & Johnson Company Details
Table 81. Johnson & Johnson Business Overview
Table 82. Johnson & Johnson Product
Table 83. Johnson & Johnson Revenue in Hidradenitis Suppurativa Treatment Business (2015-2020) (Million US$)
Table 84. Johnson & Johnson Recent Development
Table 85. Merck Company Details
Table 86. Merck Business Overview
Table 87. Merck Product
Table 88. Merck Revenue in Hidradenitis Suppurativa Treatment Business (2015-2020) (Million US$)
Table 89. Merck Recent Development
Table 90. Pfizer Company Details
Table 91. Pfizer Business Overview
Table 92. Pfizer Product
Table 93. Pfizer Revenue in Hidradenitis Suppurativa Treatment Business (2015-2020) (Million US$)
Table 94. Pfizer Recent Development
Table 95. AbbVie Company Details
Table 96. AbbVie Business Overview
Table 97. AbbVie Product
Table 98. AbbVie Revenue in Hidradenitis Suppurativa Treatment Business (2015-2020) (Million US$)
Table 99. AbbVie Recent Development
Table 100. Allergan Company Details
Table 101. Allergan Business Overview
Table 102. Allergan Product
Table 103. Allergan Revenue in Hidradenitis Suppurativa Treatment Business (2015-2020) (Million US$)
Table 104. Allergan Recent Development
Table 105. AstraZeneca Company Details
Table 106. AstraZeneca Business Overview
Table 107. AstraZeneca Product
Table 108. AstraZeneca Revenue in Hidradenitis Suppurativa Treatment Business (2015-2020) (Million US$)
Table 109. AstraZeneca Recent Development
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hidradenitis Suppurativa Treatment Market Share by Type: 2020 VS 2026
Figure 2. Medications Features
Figure 3. Surgery Features
Figure 4. Others Features
Figure 5. Global Hidradenitis Suppurativa Treatment Market Share by Application: 2020 VS 2026
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Others Case Studies
Figure 9. Hidradenitis Suppurativa Treatment Report Years Considered
Figure 10. Global Hidradenitis Suppurativa Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Hidradenitis Suppurativa Treatment Market Share by Regions: 2020 VS 2026
Figure 12. Global Hidradenitis Suppurativa Treatment Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Hidradenitis Suppurativa Treatment Market Share by Players in 2019
Figure 15. Global Top Hidradenitis Suppurativa Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hidradenitis Suppurativa Treatment as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Hidradenitis Suppurativa Treatment Revenue in 2019
Figure 17. North America Hidradenitis Suppurativa Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Hidradenitis Suppurativa Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Hidradenitis Suppurativa Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Hidradenitis Suppurativa Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Hidradenitis Suppurativa Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Hidradenitis Suppurativa Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Hidradenitis Suppurativa Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Bottom-up and Top-down Approaches for This Report
Figure 25. Data Triangulation
Figure 26. Key Executives Interviewed

以下、関連資料のご紹介

クラッベ病治療の世界市場（～2026年）

Global Krabbe Disease Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY12467 2020年11月25日 94Pages
当調査資料はクラッベ病治療のグローバル市場について調査・分析したレポートです。種類別（抗けいれん薬、筋弛緩薬、造血幹細胞移植、その他）市場規模、用途別（病院、ASC）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オー...

アレルギー性鼻炎治療の世界市場（～2026年）

Global Allergic Rhinitis Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY13652 2020年11月30日 91Pages
当調査資料はアレルギー性鼻炎治療のグローバル市場について調査・分析したレポートです。種類別（抗ヒスタミン薬、鼻腔内コルチコステロイド、免疫療法、充血除去薬、その他）市場規模、用途別（季節性アレルギー性鼻炎、通年性アレルギー性鼻炎）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イ...

変形性関節症治療の世界市場（～2026年）

Global Osteoarthritis Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY04111 2020年11月20日 98Pages
当調査資料は変形性関節症治療のグローバル市場について調査・分析したレポートです。種類別（薬物、支援機器）市場規模、用途別（病院薬局、小売薬局、オンライン薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリ...

結節性痒疹治療の世界市場（～2026年）

Global Prurigo Nodularis Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY04403 2020年11月20日 97Pages
当調査資料は結節性痒疹治療のグローバル市場について調査・分析したレポートです。種類別（カプサイシンクリーム、抗ヒスタミン薬、その他）市場規模、用途別（病院薬局、小売薬局、オンライン薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国...

多発性骨髄腫治療の世界市場（～2026年）

Global Multiple Myeloma Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY03865 2020年11月20日 92Pages
当調査資料は多発性骨髄腫治療のグローバル市場について調査・分析したレポートです。種類別（プロテアソーム阻害剤、免疫調節剤（IMiD）、ヒストンデアセチラーゼ（HDAC）阻害剤、免疫療法、細胞毒性化学療法）市場規模、用途別（病院、診療所、がん治療・リハビリテーションセンター）市場規模、地域別（北米、米...

乳糖不耐症治療の世界市場（～2026年）

Global Lactose Intolerance Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY12475 2020年11月25日 90Pages
当調査資料は乳糖不耐症治療のグローバル市場について調査・分析したレポートです。種類別（栄養補助食品、酵素ラクターゼサプリメント、その他）市場規模、用途別（病院・クリニック、在宅医療、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、...

早期陣痛治療の世界市場（～2026年）

Global Preterm Labor Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY04368 2020年11月20日 99Pages
当調査資料は早期陣痛治療のグローバル市場について調査・分析したレポートです。種類別（子宮収縮抑制薬、ベータ–模倣薬、カルシウムチャネル遮断薬、NSAIDS、コルチコステロイド、硫酸マグネシウム、抗生物質）市場規模、用途別（病院、小児科および新生児クリニック、ナーシングホーム、薬局）市場規模、地域別（...

尿路感染症治療の世界市場（～2026年）

Global Urinary Tract Infection Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY04952 2020年11月20日 99Pages
当調査資料は尿路感染症治療のグローバル市場について調査・分析したレポートです。種類別（複雑なUTI、再発性の複雑なUTI、単純なUTI、神経因性膀胱感染症、その他）市場規模、用途別（病院薬局、婦人科および泌尿器科クリニック、ドラッグストア、小売薬局、オンラインドラッグストア）市場規模、地域別（北米、...

非血液がん治療の世界市場（～2026年）

Global Non-Hematological Cancer Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY04000 2020年11月20日 97Pages
当調査資料は非血液がん治療のグローバル市場について調査・分析したレポートです。種類別（化学療法、手術、放射線療法、その他）市場規模、用途別（病院、腫瘍治療センター、外来手術センター、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、...

目アレルギー治療の世界市場（～2026年）

Global Eye Allergy Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY11906 2020年11月25日 98Pages
当調査資料は目アレルギー治療のグローバル市場について調査・分析したレポートです。種類別（薬、アレルギーショット、その他）市場規模、用途別（病院、眼科クリニック）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラ...

逆流性腎症治療の世界市場（～2026年） Reflux nephropathy is kidney damage (nephropathy) due to urine flowing backward (reflux) from the bladder toward the kidneys. The symptoms of reflux nephropathy are comparable to nephrotic syndrome and infection of the urinary tract, though some individuals may not exhibit any evidence (symptom) of …
心筋虚血治療の世界市場（～2026年） Myocardial ischemia is a condition characterized by insufficient blood flow to the heart creating a paucity of oxygen leading to heart attacks. It is also known as cardiac ischemia and the blockage of coronary artery can cause abnormal heart rhythms. The Americas are the flag-bearer, the region is g…
聴神経鞘腫治療の世界市場（～2026年） Market Analysis and Insights: Global Acoustic Neurinoma Treatment Market The global Acoustic Neurinoma Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Acoustic Neurinoma Treatment Scope and Market Size Acoust…
季節性情動障害治療の世界市場（～2026年） Seasonal Affective Disorder is a type of depression that occurs during a certain time of the year. This disorder is related to changes in seasons, mostly occurs in winter but some people may have this disorder in summers as well. Seasonal affective disorder is most common in women, people between th…
多形性膠芽腫（GBM）再発治療の世界市場（～2026年） Recurrent glioblastoma multiforme is the most aggressive cancer that begins within the brain. The increasing incidence of seizure is expected to drive the recurrent glioblastoma multiforme treatment market. Market Analysis and Insights: Global Recurrent Glioblastoma Multiforme (GBM) Treatment Market…